EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

FLT4 causes developmental disorders of the cardiovascular and lymphovascular systems via pleiotropic molecular mechanisms

Richard M Monaghan iD, Richard W Naylor iD, Daisy Flatman, Paul R Kasher iD, Simon G Williams iD, Bernard D Keavney iD

Cardiovascular Research · 2024

DOI: 10.1093/cvr/cvae104 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Research, 2024. Verfasst von Richard M Monaghan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine, and Health, Manchester Academic Health Science Centre,…. Hauptthemen laut MEDLINE: Signal Transduction, Tetralogy of Fallot, Vascular Endothelial Growth Factor Receptor-3, Zebrafish. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: British Heart Foundation, NIHR Manchester Biomedical Research Centre, Kidney Research UK Intermediate Fellowship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Rare, deleterious genetic variants in FLT4 are associated with Tetralogy of Fallot (TOF), the most common cyanotic congenital heart disease. The distinct genetic variants in FLT4 are also an established cause of Milroy disease, the most prevalent form of primary hereditary lymphoedema. The phenotypic features of these two conditions are non-overlapping, implying pleiotropic cellular mechanisms during development. Methods and results In this study, we show that FLT4 variants identified in patients with TOF, when expressed in primary human endothelial cells, cause aggregation of FLT4 protein in the perinuclear endoplasmic reticulum, activating proteostatic and metabolic signalling, whereas lymphoedema-associated FLT4 variants and wild-type (WT) FLT4 do not. FLT4 TOF variants display characteristic gene expression profiles in key developmental signalling pathways, revealing a role for FLT4 in cardiogenesis distinct from its role in lymphatic development. Inhibition of proteostatic signalling abrogates these effects, identifying potential avenues for therapeutic intervention. Depletion of flt4 in zebrafish caused cardiac phenotypes of reduced heart size and altered heart looping. These phenotypes were rescued with coinjection of WT human FLT4 mRNA, but incompletely or not at all by mRNA harbouring FLT4 TOF variants.

Conclusion

Taken together, we identify a pathogenic mechanism for FLT4 variants predisposing to TOF that is distinct from the known dominant negative mechanism of Milroy-causative variants. FLT4 variants give rise to conditions of the two circulatory subdivisions of the vascular system via distinct developmental pleiotropic molecular mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Signal TransductionTetralogy of FallotVascular Endothelial Growth Factor Receptor-3ZebrafishZebrafish ProteinsAnimalsHumansCells, CulturedEndoplasmic ReticulumEndothelial CellsGene Expression Regulation, DevelopmentalGenetic Predisposition to DiseaseHuman Umbilical Vein Endothelial CellsLymphedemaMutationPhenotype

Stichwörter der Autor:innen

Congenital heart diseaseDevelopmental pleiotropyFLT4Primary lymphoedemaProteostasisTetralogy of FallotVEGFR3

Substanzen

FLT4 protein, humanVascular Endothelial Growth Factor Receptor-3Zebrafish Proteins

Autor:innen und Institutionen

  • Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine, and Health, Manchester Academic Health Science Centre, University of Manchester, 5th Floor, AV Hill Building, Oxford Road, M…
  • Wellcome Centre for Cell Matrix Research, Division of Cell Matrix Biology and Regenerative Medicine, School of Biological Sciences, Faculty of Biology, Medicine, and Health, Manchester Academic Health Science Centre, Un…
  • Division of Neuroscience and Experimental Psychology, School of Biological Sciences, University of Manchester, Oxford Road, Manchester, M13 9PT, UK.
  • Geoffrey Jefferson Brain Research Centre, Manchester Academic Health Science Centre, Northern Care Alliance NHS Foundation Trust, University of Manchester, Oxford Road, Manchester, M13 9PT, UK.
  • Manchester Heart Institute, Manchester University NHS Foundation Trust, Oxford Road, M13 9WL, UK.

ORCID-Profile: Richard M Monaghan, Richard W Naylor, Paul R Kasher, Simon G Williams, Bernard D Keavney

Förderung

  • British Heart Foundation
  • NIHR Manchester Biomedical Research Centre
  • Kidney Research UK Intermediate Fellowship
  • Medical Research Council

Zitieren

APA

Monaghan, R. M., Naylor, R. W., Flatman, D., Kasher, P. R., Williams, S. G., & Keavney, B. D. (2024). FLT4 causes developmental disorders of the cardiovascular and lymphovascular systems via pleiotropic molecular mechanisms. Cardiovascular Research. https://doi.org/10.1093/cvr/cvae104

Vancouver

Monaghan RM, Naylor RW, Flatman D, Kasher PR, Williams SG, Keavney BD. FLT4 causes developmental disorders of the cardiovascular and lymphovascular systems via pleiotropic molecular mechanisms. Cardiovascular Research. 2024. doi:10.1093/cvr/cvae104

BibTeX
@article{Monaghan2024,
  author = {Monaghan, Richard M and Naylor, Richard W and Flatman, Daisy and Kasher, Paul R and Williams, Simon G and Keavney, Bernard D},
  title = {FLT4 causes developmental disorders of the cardiovascular and lymphovascular systems via pleiotropic molecular mechanisms},
  journal = {Cardiovascular Research},
  year = {2024},
  doi = {10.1093/cvr/cvae104}
}
Kostenlos starten →